Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β 2 -agonists.

Published in: Respirology (Carlton, Vic.) (2023)

-agonist treatment and should now be investigated as a possible biomarker.

Keyphrases